Starting a Hepatitis C Elimination Program at Lummi

DISCLOSURES
This activity is jointly provided by Northwest Portland Area
Indian Health Board and Cardea
Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association, an accredited approver with
distinction by the American Nurses Credentialing Center’s Commission on Accreditation.
This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Institute for Medical
Quality/California Medical Association (IMQ/CMA) through the joint providership of Cardea and Northwest Portland Area Indian Health Board.
Cardea is accredited by the IMQ/CMA to provide continuing medical education for physicians.
Cardea designates this in-person training for a maximum of 7 
AMA PRA Category 1 Credit(s)
TM
. Physicians should claim credit commensurate
with the extent of their participation in the activity.
 
DISCLOSURES
COMPLETING THIS ACTIVITY
Upon successful completion of this activity 7 contact hours will be awarded
Successful completion of this continuing education activity includes the following:
Attending the entire CE activity;
Completing the online evaluation;
Submitting an online CE request.
Your certificate will be sent via email
If you have any questions about this CE activity, contact Michelle Daugherty at
 
or (206) 447-9538
mdaugherty@cardeaservices.org
 
None of the planners or presenters of this CE activity
have any relevant financial relationships with any
commercial entities pertaining to this activity.
CONFLICT OF INTEREST
 
Acknowledgement
  
This event is funded in part by:
The  Indian Health Service HIV Program
and
The Secretary’s Minority AIDS Initiative Fund
 
Objectives
 By the end of this learning event participants will be able to:
Define elimination as it relates to infectious disease
Identify interventions required to achieve HCV elimination
Describe Lummi HCV elimination program
 
Starting a Hepatitis C Elimination
Program at Lummi
Justin Iwasaki MD MPH
Executive Medical Director
Lummi Tribal Health Center
HCV ELIMINATION
Elimination
Reduction to zero of the incidence of disease or
infection in a defined geographical area.
World Health Organization
http://www.who.int/bulletin/volumes/84/2/editorial10206html/en/
 
 
HCV ELIMINATION
HCV is a Public Health Problem Requiring a Public Health
Response
Treatment as Prevention
Incidence of Acute Hepatitis C
by Race/Ethnicity (USA)
Source: National Notifiable Diseases Surveillance
System (NNDSS)
Source: National Notifiable Diseases Surveillance
System (NNDSS)
80% of New HCV Infections Occur in People Who
Inject Drugs (PWID)
HCV ELIMINATION
Super Infectors +Usual Infectors+Non-Infectors
HCV ELIMINATION
HCV Program Design Considerations
PWID May Not Fit the Usual Healthcare Delivery Model We Created
 
Scheduled Office Visits
Follow Up with Testing and Imaging and Future Appointments
Convenient Contact with Telephone or Mail
Reliable Transportation
Ability to Safely Store Medication
Predictable Changes to Home Life: Hospitalization, 
 
Incarceration,
Drug/Alcohol Rehab
Family and Friend Support
 
HCV ELIMINATION
We Had to Create A New Model of Healthcare Delivery
 
CASCADE OF CARE
Example from the University of BC
HCV ELIMINATION
Two Components of the Program
Getting the Patient Ready for Treatment
Treatment and Monitoring
HCV ELIMINATION
Getting the Patient Ready for Treatment
HCV Project Coordinator (RN) and Assistant
Initially, required multiple visits, could not get
outside imaging, significant amount of
human resources.
Partnered with NWPAIHB to Establish a
Single Visit Ready to Treat Program
Single Visit Ready to Treat Program
Rapid HCV Ab Test
HCV RNA with Reflex to
Genotype 
(standing orders)
BMP
LFT
INR
CBC
*Fibroscan
Re-Screen Based on
Exposure History
Positive
Negative
Chronic HCV
No Chronic HCV
Retest HCV
RNA q6month
Present to Project ECHO
Start Treatment
Submit Prior Authorization
Day 0
4-6 Weeks
Day 1
Fibroscan: calculates liver stiffness based
on sound wave.
Non-invasive.  10-15 Minutes.
RN, Rad Tech, MD
HCV ELIMINATION
HCV ELIMINATION
Treatment and Monitoring
Medication Compliance
 
Daily, Weekly, Bi-Monthly
 
Partner with Opioid Treatment Program
Home Visits and Outreach
Lummi HCV Cascade of Care
 
Number of Patients
79%
HCV ELIMINATION
Screened 1861 of 5775 Adult Patients
for HCV
Initiating Treatment ~5 Patients Per
Month
Eliminate HCV 2021*
HCV ELIMINATION
All Patients Care About Treatment
Untreated bipolar, homeless/living on sail
boat,frequent drug use. YWCA, Shelter, ER.
Arrested Patient: “Not Without My Harvoni”
HCV ELIMINATION
Thank You
Jessica Leston and David Stephens
NWPAIHB
Dr. Jorge Mera
Jessica Rienstra HCV Project
Coordinator
Kim Schiller HCV Project Assistant
Slide Note
Embed
Share

Learn about the Hepatitis C elimination program at Lummi Tribal Health Center, focusing on defining elimination, required interventions for HCV elimination, and the Lummi program's description. The activity offers 7 contact hours upon completion. No conflicts of interest are present, and the event is partially funded by the Indian Health Service HIV Program and Secretary's Minority AIDS Initiative Fund.

  • Hepatitis C
  • Lummi Tribal Health Center
  • Continuing Education
  • Infectious Disease
  • Medical Education

Uploaded on Oct 04, 2024 | 1 Views


Download Presentation

Please find below an Image/Link to download the presentation.

The content on the website is provided AS IS for your information and personal use only. It may not be sold, licensed, or shared on other websites without obtaining consent from the author. Download presentation by click this link. If you encounter any issues during the download, it is possible that the publisher has removed the file from their server.

E N D

Presentation Transcript


  1. DISCLOSURES This activity is jointly provided by Northwest Portland Area Indian Health Board and Cardea Cardea Services is approved as a provider of continuing nursing education by Montana Nurses Association, an accredited approver with distinction by the American Nurses Credentialing Center s Commission on Accreditation. This activity has been planned and implemented in accordance with the accreditation requirementsand policies of the Institute for Medical Quality/California Medical Association (IMQ/CMA) through the joint providershipof Cardea and Northwest Portland Area Indian Health Board. Cardea is accredited by the IMQ/CMA to provide continuing medical education for physicians. Cardea designates this in-person training for a maximum of 7 AMA PRA Category 1 Credit(s)TM. Physicians should claim credit commensurate with the extent of their participation in the activity.

  2. DISCLOSURES COMPLETING THIS ACTIVITY Upon successful completion of this activity 7 contact hours will be awarded Successful completion of this continuing education activity includes the following: Attending the entire CE activity; Completing the online evaluation; Submitting an online CE request. Your certificate will be sent via email If you have any questions about this CE activity, contact Michelle Daugherty at mdaugherty@cardeaservices.org or (206) 447-9538

  3. CONFLICT OF INTEREST None of the planners or presenters of this CE activity have any relevant financial relationships with any commercial entities pertaining to this activity.

  4. Acknowledgement This event is funded in part by: The Indian Health Service HIV Program and The Secretary s Minority AIDS Initiative Fund

  5. Objectives By the end of this learning event participants will be able to: Define elimination as it relates to infectious disease Identify interventions required to achieve HCV elimination Describe Lummi HCV elimination program

  6. Starting a Hepatitis C Elimination Program at Lummi Justin Iwasaki MD MPH Executive Medical Director Lummi Tribal Health Center

  7. Elimination Reduction to zero of the incidence of disease or infection in a defined geographical area. World Health Organization HCV ELIMINATION http://www.who.int/bulletin/volumes/84/2/editorial10206html/en/

  8. HCV is a Public Health Problem Requiring a Public Health Response Treatment as Prevention HCV ELIMINATION

  9. Incidence of Acute Hepatitis C by Race/Ethnicity (USA) Reported cases/100,000 population 3.5 American Indian/Alaska Native Asian/Pacific Islander 3 2.5 Black, Non-Hispanic 2 White, Non-Hispanic 1.5 1 0.5 0 Year Source: National Notifiable Diseases Surveillance System (NNDSS)

  10. 80% of New HCV Infections Occur in People Who Inject Drugs (PWID) Source: National Notifiable Diseases Surveillance System (NNDSS)

  11. Super Infectors +Usual Infectors+Non-Infectors HCV ELIMINATION

  12. HCV Program Design Considerations PWID May Not Fit the Usual Healthcare Delivery Model We Created Scheduled Office Visits Follow Up with Testing and Imaging and Future Appointments Convenient Contact with Telephone or Mail Reliable Transportation Ability to Safely Store Medication Predictable Changes to Home Life: Hospitalization, Incarceration, Drug/Alcohol Rehab Family and Friend Support HCV ELIMINATION

  13. We Had to Create A New Model of Healthcare Delivery HCV ELIMINATION

  14. CASCADE OF CARE Image result for care cascade Example from the University of BC

  15. Two Components of the Program Getting the Patient Ready for Treatment Treatment and Monitoring HCV ELIMINATION

  16. Getting the Patient Ready for Treatment HCV Project Coordinator (RN) and Assistant Initially, required multiple visits, could not get outside imaging, significant amount of human resources. Partnered with NWPAIHB to Establish a Single Visit Ready to Treat Program HCV ELIMINATION

  17. Single Visit Ready to Treat Program Day 0 Rapid HCV Ab Test Positive Negative HCV RNA with Reflex to Genotype (standing orders) BMP LFT INR CBC *Fibroscan Re-Screen Based on Exposure History Day 1 No Chronic HCV Chronic HCV Retest HCV RNA q6month Present to Project ECHO Submit Prior Authorization 4-6 Weeks Start Treatment

  18. Fibroscan: calculates liver stiffness based on sound wave. Non-invasive. 10-15 Minutes. RN, Rad Tech, MD HCV ELIMINATION

  19. Treatment and Monitoring Medication Compliance Daily, Weekly, Bi-Monthly Partner with Opioid Treatment Program Home Visits and Outreach HCV ELIMINATION

  20. Lummi HCV Cascade of Care 700 600 500 400 74% Number of Patients 300 200 366 269 56 % 73% 100 65% 150 97 79% 77 0 HCV Antibody + Estimated HCV Antibody + Detected HCV RNA Done HCV RNA Positive Evaluated Treated

  21. Screened 1861 of 5775 Adult Patients for HCV Initiating Treatment ~5 Patients Per Month Eliminate HCV 2021* HCV ELIMINATION

  22. All Patients Care About Treatment Untreated bipolar, homeless/living on sail boat,frequent drug use. YWCA, Shelter, ER. Arrested Patient: Not Without My Harvoni HCV ELIMINATION

  23. Thank You Jessica Leston and David Stephens NWPAIHB Dr. Jorge Mera Jessica Rienstra HCV Project Coordinator Kim Schiller HCV Project Assistant HCV ELIMINATION

Related


More Related Content

giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#giItT1WQy@!-/#